Skip to secondary navigation Skip to main navigation Skip navigation Skip to main content

This website is fully funded and supported by Gilead Sciences Europe Ltd

  • Liver Disease Toolkit
    • Hepatitis C toolkit
    • Hepatitis B toolkit
  • About Us
  • UK
    • Australia
    • Belgium
  • Hepatitis C
    • Community-based management of HCV
    • Assessment and diagnosis
    • Expert insights
    • Hep C Free Hub
  • Hepatitis B
    • HBV E Learning
    • The burden of HBV
    • HBV prevention and diagnosis
    • HBV treatment and management
    • HBV expert insights
  • Journey to elimination
    • Winning the Race to Eliminate Hepatitis C Report
    • Geographic populations
    • Resource-limited settings
    • Marginalised populations
  • SLTC 2020
  • Stories
  • Specialisms
    • Addiction and harm reduction
    • Hepatology
    • Primary Care Providers
  • News and Events
    • Conferences and Events
    • Expert insights
    • News and Publications
    • Video Hub
Home » Telemedicine to treat patients with liver disease and after liver transplantation in outpatient clinics in Sydney, Australia

Telemedicine to treat patients with liver disease and after liver transplantation in outpatient clinics in Sydney, Australia

Popular Posts

Affiliates Resource

SLTC in the COVID-era: a global video

Read more
Affiliates Resource

JAILFREE-C Programme

Read more
Affiliates Resource

The Catalan model of hepatitis care

Read more
  • About Us
  • Liver Disease Toolkit
  • Publications and Events
  • Specialist interests
  • Hepatitis B
  • Hepatitis C
Gilead Sciences © 2009-2021. All rights reserved. 2 ROUNDWOOD AVENUE, STOCKLEY PARK, UXBRIDGE, UB11 1AF, 020 8587 2200, EMEAMED.INFO@GILEAD.COM
  • Terms of Use
  • Privacy Policy
  • Cookie Statement
IHQ/LVD/2020-02//0001

Disclaimer: Images on this website are stock photos posed by models.

DISCLAIMER: This link will take you to an external website.

Cancel Accept
DISCLAIMER: This link will take you to an external website.

Hepatichealth.com is a site created for healthcare professionals and those professionally involved in treatment pathways for viral Hepatitis.

Enter site